Pluri Inc.

Regulatory Filings • Dec 17, 2019

_________ false

�������� ��������� ����	2 381
PLURISTEM THERAPEUTICS INC
Corporation no: C12337-2001	8543
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C003 ( Public )		Reported via MAGNA:	17/12/2019
	www.isa.gov.il			www.tase.co.il				Reference:	2019-02-121846	Time of broadcast: 13:58 13:57:14

---

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on	Pluristem Completes 75% Enrollment in its Pivotal Phase III CLI Clinical Study

PSTI_75percent_Enrollment_CLI_FINAL_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 03/12/2019
Address: Matam Park 5 , Haifa 31905   ISRAEL , Tel: 074-7107171 , Fax: 074-7107172
E-mail address: Info@Pluristem.Com   Company site: www.pluristem.com
Previous names of reporting entity:
Name of the Signatory: Yanay Yaacov Position of Signatory in the reporting corporation: Chief Executive Officer, Director Name of Employer Company:
Address: Matam Park 5 , Haifa 31905 Telephone: 074-7107171 Facsimile: 074-7108673 E-mail: yaky@pluristem.com 1